Swine as a model for influenza avirus infection and immunity

ILAR Journal

Volumn 56, Issue 1, 2015, Pages 44-52

  Rajao, Daniela S ^b   Vincent, Amy L ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b NONE

Author keywords

Animal model; Human; Immunity; Infection; Influenza a virus; Swine

Indexed keywords

ANIMALIA; AVES; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

ANIMAL; DISEASE MODEL; IMMUNOLOGY; INFLUENZA A VIRUS; METABOLISM; ORTHOMYXOVIRUS INFECTION; PIG; SWINE DISEASE; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; SWINE DISEASES;

EID: 84939513250     PISSN: 10842020     EISSN: 19306180     Source Type: Journal    
DOI: 10.1093/ilar/ilv002     Document Type: Article

References (111)

1. Anderson TK, Nelson MI, Kitikoon P, Swenson SL, Korslund JA, Vincent AL. 2013. Population dynamics of cocirculating swine influenza A viruses in the United States from 2009 to 2012. Influenza Other Respir Viruses 7(Suppl 4): 42-51.
2. Barnard DL. 2009. Animal models for the study of influenza pathogenesis and therapy. Antiviral Res 82:A110-A122.
3. Bellinger DA, Merricks EP, Nichols TC. 2006. Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J 47:243-258.
4. Bikour MH, Cornaglia E, Elazhary Y. 1996. Evaluation of a protective immunity induced by an inactivated influenza H3N2 vaccine after an intratracheal challenge of pigs. Can J Vet Res 60:312-314.
5. Bouvier NM, Lowen AC. 2010. Animal models for influenza virus pathogenesis and transmission. Viruses 2:1530-1563.
6. Brookes SM, Nunez A, Choudhury B, Matrosovich M, Essen SC, Clifford D, Slomka MJ, Kuntz-Simon G, Garcon F, Nash B, Hanna A, Heegaard PM, Queguiner S, Chiapponi C, Bublot M, Garcia JM, Gardner R, Foni E, Loeffen W, Larsen L, Van Reeth K, Banks J, Irvine RM, Brown IH. 2010. Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs. PLoS One 5:e9068.
7. Buchman CA, Swarts JD, Seroky JT, Panagiotou N, Hayden F, Doyle WJ. 1995. Otologic and systemic manifestations of experimental influenza A virus infection in the ferret. Otolaryngol Head Neck Surg 112:572-578.
8. Bui M, Whittaker G, Helenius A. 1996. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J Virol 70:8391-8401.
9. Byrd-Leotis L, Liu R, Bradley KC, Lasanajak Y, Cummings SF, Song X, Heimburg-Molinaro J, Galloway SE, Culhane MR, Smith DF, Steinhauer DA, Cummings RD. 2014. Shotgun glycomics of pig lung identifies natural endogenous receptors for influenza viruses. ProcNatl Acad Sci USA 111:E2241-E2250.
10. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. 2008. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 167:775-785.
11. Chan RW, Kang SS, Yen HL, Li AC, Tang LL, Yu WC, Yuen KM, Chan IW, Wong DD, Lai WW, Kwong DL, Sihoe AD, Poon LL, Guan Y, Nicholls JM, Peiris JS, Chan MC. 2011. Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. J Virol 85:11581-11587.
12. Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R. 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 26:107-113.
13. Childs RA, Palma AS, Wharton S, Matrosovich T, Liu Y, Chai W, Campanero-Rhodes MA, Zhang Y, Eickmann M, Kiso M, Hay A, Matrosovich M, Feizi T. 2009. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 27:797-799.
14. Choi HK, FinkbeinerWE, Widdicombe JH. 2000.Acomparative study of mammalian tracheal mucous glands. J Anat 197:361-372.
15. Chutinimitkul S, van Riel D, Munster VJ, van den Brand JM, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA, de Wit E. 2010. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza Aviruses with altered receptor specificity. J Virol 84:6825-6833.
16. Clements ML, Betts RF, Tierney EL, Murphy BR. 1986. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 24:157-160.
17. Cox RJ, Brokstad KA, Ogra P. 2004. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. Scand J Immunol 59:1-15.
18. Dawson HD. 2011. A comparative assessment of the pig, mouse, and human genomes: structural and functional analysis of genes involved in immunity and inflammation. In:McAnulty PA, Dayan AD, Ganderup N, Hastings KL, eds. The Minipig in Biomedical Research. Boca Raton: CRC Press. p 323-342.
19. de Jong JC, Beyer WE, Palache AM, Rimmelzwaan GF, Osterhaus AD. 2000. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 61:94-99.
20. de Jong JC, Smith DJ, Lapedes AS, Donatelli I, Campitelli L, Barigazzi G, Van Reeth K, Jones TC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2007. Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe. J Virol 81:4315-4322.
21. de Vries E, de Vries RP, Wienholts MJ, Floris CE, Jacobs MS, van den Heuvel A, Rottier PJ, de Haan CA. 2012. Influenza A virus entry into cells lacking sialylated N-glycans. Proc Natl Acad Sci USA 109:7457-7462.
22. Epperson S, Jhung M, Richards S, Quinlisk P, Ball L, Moll M, Boulton R, Haddy L, Biggerstaff M, Brammer L, Trock S, Burns E, Gomez T, Wong KK, Katz J, Lindstrom S, Klimov A, Bresee JS, Jernigan DB, Cox N, Finelli L. 2013. Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis. 57:S4-S11.
23. Fan N, Lai L. 2013. Genetically modified pig models for human diseases. J Genet Genomics 40:67-73.
24. Fontana J, Cardone G, Heymann JB, Winkler DC, Steven AC. 2012. Structural changes in Influenza virus at low pH characterized by cryo-electron tomography. J Virol 86:2919-2929.
25. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD. 2005. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814-2822.
26. Galloway SE, Reed ML, Russell CJ, Steinhauer DA. 2013. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog 9:e1003151.
27. Gambaryan AS, Tuzikov AB, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Bovin NV, Matrosovich MN. 1997. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers:non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6′-sialyl (N-acetyllactosamine). Virology 232:345-350.
28. Gambaryan A, Yamnikova S, Lvov D, Tuzikov A, Chinarev A, Pazynina G, Webster R, Matrosovich M, Bovin N. 2005. Receptor specificity of influenza viruses from birds and mammals:new data on involvement of the inner fragments of the carbohydrate chain. Virology 334:276-283.
29. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, Okomo-Adhiambo M, Gubareva L, Barnes J, Smith CB, Emery SL, Hillman MJ, Rivailler P, Smagala J, de Graaf M, Burke DF, Fouchier RA, Pappas C, Alpuche-Aranda CM, Lopez-Gatell H, Olivera H, Lopez I, Myers CA, Faix D, Blair PJ, Yu C, Keene KM, Dotson PD Jr., Boxrud D, Sambol AR, Abid SH, St George K, Bannerman T, Moore AL, Stringer DJ, Blevins P, Demmler-Harrison GJ, Ginsberg M, Kriner P, Waterman S, Smole S, Guevara HF, Belongia EA, Clark PA, Beatrice ST, Donis R, Katz J, Finelli L, Bridges CB, Shaw M, Jernigan DB, Uyeki TM, Smith DJ, Klimov AI, Cox NJ. 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
30. Gauger PC, Vincent AL, Loving CL, Lager KM, Janke BH, Kehrli ME Jr., Roth JA. 2011. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 29:2712-2719.
31. Groenen MA, Archibald AL, Uenishi H, Tuggle CK, Takeuchi Y, Rothschild MF, Rogel-Gaillard C, Park C, Milan D, Megens HJ, Li S, Larkin DM, Kim H, Frantz LA, Caccamo M, Ahn H, Aken BL, Anselmo A, Anthon C, Auvil L, Badaoui B, Beattie CW, Bendixen C, Berman D, Blecha F, Blomberg J, Bolund L, Bosse M, Botti S, Bujie Z, Bystrom M, Capitanu B, Carvalho-Silva D, Chardon P, Chen C, Cheng R, Choi SH, Chow W, Clark RC, Clee C, Crooijmans RP, Dawson HD, Dehais P, De Sapio F, Dibbits B, Drou N, Du ZQ, Eversole K, Fadista J, Fairley S, Faraut T, Faulkner GJ, Fowler KE, Fredholm M, Fritz E, Gilbert JG, Giuffra E, Gorodkin J, Griffin DK, Harrow JL, Hayward A, Howe K, Hu ZL, Humphray SJ, Hunt T, Hornshoj H, Jeon JT, Jern P, Jones M, Jurka J, Kanamori H, Kapetanovic R, Kim J, Kim JH, Kim KW, Kim TH, Larson G, Lee K, Lee KT, Leggett R, Lewin HA, Li Y, Liu W, Loveland JE, Lu Y, Lunney JK, Ma J, Madsen O, Mann K, Matthews L, McLaren S, Morozumi T, Murtaugh MP, Narayan J, Nguyen DT, Ni P, Oh SJ, Onteru S, Panitz F, Park EW, Park HS, Pascal G, Paudel Y, Perez-Enciso M, Ramirez-Gonzalez R, Reecy JM, Rodriguez-Zas S, Rohrer GA, Rund L, Sang Y, Schachtschneider K, Schraiber JG, Schwartz J, Scobie L, Scott C, Searle S, Servin B, Southey BR, Sperber G, Stadler P, Sweedler JV, Tafer H, Thomsen B, Wali R, Wang J, Wang J, White S, Xu X, Yerle M, Zhang G, Zhang J, Zhang J, Zhao S, Rogers J, Churcher C, Schook LB. 2012. Analyses of pig genomes provide insight into porcine demography and evolution. Nature 491:393-398.
32. Gulati S, Smith DF, Cummings RD, Couch RB, Griesemer SB, St George K, Webster RG, Air GM. 2013. Human H3N2 influenza viruses isolated from 1968 to 2012 show varying preference for receptor substructures with no apparent consequences for disease or spread. PLoS One 8:e66325.
33. Hayden FG, Fritz R, Lobo MC, AlvordW, StroberW, Straus SE. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101:643-649.
34. Heinen PP, de Boer-Luijtze EA, Bianchi AT. 2001. Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection. J Gen Virol 82:2697-2707.
35. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541.
36. Herlocher ML, Elias S, Truscon R, Harrison S, Mindell D, Simon C, Monto AS. 2001. Ferrets as a transmission model for influenza:sequence changes in HA1 of type A (H3N2) virus. J Infect Dis 184:542-546.
37. Humphray SJ, Scott CE, Clark R, Marron B, Bender C, Camm N, Davis J, Jenks A, Noon A, Patel M, Sehra H, Yang F, Rogatcheva MB, Milan D, Chardon P, Rohrer G, Nonneman D, de Jong P, Meyers SN, Archibald A, Beever JE, Schook LB, Rogers J. 2007. A high utility integrated map of the pig genome. Genome Biol 8:R139.
38. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL. 2006. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 80:7469-7480.
39. Imai M, Kawaoka Y. 2012. The role of receptor binding specificity in interspecies transmission of influenza viruses. Curr Opin Virol 2:160-167.
40. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y. 1998. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72:7367-7373.
41. Janke BH. 2013. Clinicopathological features of swine influenza. Curr Top Microbiol Immunol 370:69-83.
42. Jhung MA, Epperson S, Biggerstaff M, Allen D, Balish A, Barnes N, Beaudoin A, Berman L, Bidol S, Blanton L, Blythe D, Brammer L, D'Mello T, Danila R, Davis W, de Fijter S, Diorio M, Durand LO, Emery S, Fowler B, Garten R, Grant Y, Greenbaum A, Gubareva L, Havers F, Haupt T, House J, Ibrahim S, Jiang V, Jain S, Jernigan D, Kazmierczak J, Klimov A, Lindstrom S, Longenberger A, Lucas P, Lynfield R, McMorrow M, Moll M, Morin C, Ostroff S, Page SL, Park SY, Peters S, Quinn C, Reed C, Richards S, Scheftel J, Simwale O, Shu B, Soyemi K, Stauffer J, Steffens C, Su S, Torso L, Uyeki TM, Vetter S, Villanueva J, Wong KK, Shaw M, Bresee JS, Cox N, Finelli L. 2013. Outbreak of variant influenza A (H3N2) virus in the United States. Clin Infect Dis 57:1703-1712.
43. Judge EP, Hughes JM, Egan JJ, Maguire M, Molloy EL, O'Dea S. 2014. Anatomy and bronchoscopy of the porcine lung. A model for translational respiratory medicine. Am J Respir Cell Mol Biol 51:334-343.
44. Khatri M, Dwivedi V, Krakowka S, Manickam C, Ali A, Wang L, Qin Z, Renukaradhya GJ, Lee CW. 2010. Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus. J Virol 84:11210-11218.
45. Kida H, Ito T, Yasuda J, Shimizu Y, Itakura C, Shortridge KF, Kawaoka Y, Webster RG. 1994. Potential for transmission of avian influenza viruses to pigs. J Gen Virol 75(Pt 9): 2183-2188.
46. Kitikoon P, Vincent AL, Gauger PC, Schlink SN, Bayles DO, Gramer MR, Darnell D, Webby RJ, Lager KM, Swenson SL, Klimov A. 2012. Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J Virol 86:6804-6814.
47. Klenk HD, Rott R, Orlich M, Blodorn J. 1975. Activation of influenza A viruses by trypsin treatment. Virology 68:426-439.
48. Koen JS. 1919. A practical method for field diagnosis of swine diseases. Am J Vet Med 14:468-470.
49. Kreijtz JH, Bodewes R, van Amerongen G, Kuiken T, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2007. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 25:612-620.
50. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. 2007. A question of self-preservation: immunopathology in influenza virus infection. Immunol Cell Biol 85:85-92.
51. Loving CL, Vincent AL, Pena L, Perez DR. 2012. Heightened adaptive immune responses following vaccination with a temperature- sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs. Vaccine 30:5830-5838.
52. Lowen AC, Bouvier NM, Steel J. 2014. Transmission in the Guinea pig model. Curr Top Microbiol Immunol 385:157-183.
53. Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P. 2006. The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci USA 103:9988-9992.
54. Maher JA, DeStefano J. 2004. The ferret: an animal model to study influenza virus. Lab Anim (NY) 33:50-53.
55. McGill J, Heusel JW, Legge KL. 2009. Innate immune control and regulation of influenza virus infections. J Leukoc Biol 86:803-812.
56. Memoli MJ, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K, Hagey R, Voell J, Fiorentino C, Ademposi A, Shoham S, Taubenberger JK. 2014. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 58:214-224.
57. Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. 2012. The pig: a model for human infectious diseases. Trends Microbiol 20:50-57.
58. Mitchell AD. 2007. Impact of research with cattle, pigs, and sheep on nutritional concepts: body composition and growth. J Nutr 137:711-714.
59. Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J. 1995. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13:1006-1012.
60. Monsalvo AC, Batalle JP, Lopez MF, Krause JC, Klemenc J, Hernandez JZ, Maskin B, Bugna J, Rubinstein C, Aguilar L, Dalurzo L, Libster R, Savy V, Baumeister E, Aguilar L, Cabral G, Font J, Solari L, Weller KP, Johnson J, Echavarria M, Edwards KM, Chappell JD, Crowe JE Jr., Williams JV, Melendi GA, Polack FP. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 17:195-199.
61. Morens DM, Taubenberger JK. 2011. Pandemic influenza: certain uncertainties. Rev Med Virol 21:262-284.
62. MyersKP, Olsen CW, GrayGC. 2007. Cases of swine influenza inhumans:a review of the literature. Clin Infect Dis 44:1084-1088.
63. Nakakuki S. 1994. Bronchial tree, lobular division and blood vessels of the pig lung. J Vet Med Sci 56:685-689.
64. Nelli RK, Kuchipudi SV, White GA, Perez BB, Dunham SP, Chang KC. 2010. Comparative distribution of human and avian type sialic acid influenza receptors in the pig. BMC Vet Res 6:4.
65. Nelson MI, Wentworth DE, Culhane MR, Vincent AL, Viboud C, LaPointe MP, Lin X, Holmes EC, Detmer SE. 2014. Introductions and evolution of human-origin seasonal influenza a viruses in multinational Swine populations. J Virol 88:10110-10119.
66. Neumann G, Kawaoka Y. 2006. Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis 12:881-886.
67. Nicholls JM, Bourne AJ, Chen H, Guan Y, Peiris JS. 2007. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 8:73.
68. Peitsch C, Klenk HD, GartenW, Bottcher-Friebertshauser E. 2014. Activation of influenza A viruses by host proteases from swine airway epithelium. J Virol 88:282-291.
69. Pica N, Bouvier NM. 2012. Environmental factors affecting the transmission of respiratory viruses. Curr Opin Virol 2:90-95.
70. Piriou-Guzylack L, Salmon H. 2008. Membrane markers of the immune cells in swine: an update. Vet Res 39:54.
71. PotterCW, Oxford JS. 1979. Determinants of immunity to influenza infection in man. Br Med Bull 35:69-75.
72. Rajao DS, Anderson TK, Gauger PC, Vincent AL. 2014. Pathogenesis and vaccination of influenza A virus in swine. Curr Top Microbiol Immunol.
73. Richt JA, Lager KM, Janke BH, Woods RD, Webster RG, Webby RJ. 2003. Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. J Clin Microbiol 41:3198-3205.
74. Rogers CS, Abraham WM, Brogden KA, Engelhardt JF, Fisher JT, McCray PB Jr., McLennan G, Meyerholz DK, Namati E, Ostedgaard LS, Prather RS, Sabater JR, Stoltz DA, Zabner J, Welsh MJ. 2008. The porcine lung as a potential model for cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 295:L240-L263.
75. Rogers GN, Paulson JC. 1983. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127:361-373.
76. Scholtissek C, Burger H, Kistner O, Shortridge KF. 1985. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 147:287-294.
77. Schook LB, Beever JE, Rogers J, Humphray S, Archibald A, Chardon P, Milan D, Rohrer G, Eversole K. 2005. Swine Genome Sequencing Consortium (SGSC): a strategic roadmap for sequencing the pig genome. Comp Funct Genomics 6:251-255.
78. Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, Lindstrom S, Gubareva LV, Deyde V, Garten RJ, Harris M, Gerber S, Vagasky S, Smith F, Pascoe N, Martin K, Dufficy D, Ritger K, Conover C, Quinlisk P, Klimov A, Bresee JS, Finelli L. 2009. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360:2616-2625.
79. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. 2006. Avian flu: influenza virus receptors in the human airway. Nature 440:435-436.
80. Shu B, Garten R, Emery S, Balish A, Cooper L, SessionsW, Deyde V, Smith C, Berman L, Klimov A, LindstromS, Xu X. 2012. Genetic analysis and antigenic characterization of swine origin influenza viruses isolated fromhumans in the United States, 1990-2010. Virology 422:151-160.
81. Simon GA, Maibach HI. 2000. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview. Skin Pharmacol Appl Skin Physiol 13:229-234.
82. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, Ouhoummane N, Willison DJ, Rouleau I, Petric M, Fonseca K, Drews SJ, Rebbapragada A, Charest H, Hamelin ME, Boivin G, Gardy JL, Li Y, Kwindt TL, Patrick DM, Brunham RC. 2010. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 7:e1000258.
83. Smith GJ, Bahl J, Vijaykrishna D, Zhang J, Poon LL, Chen H, Webster RG, Peiris JS, Guan Y. 2009a. Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci USA 106:11709-11712.
84. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. 2009b. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125.
85. Smith W, Andrewes CH, Laidlaw PP. 1933. AVirus obtained from influenza patients. Lancet 222:66-68.
86. Stein RA. 2011. Super-spreaders in infectious diseases. Int J Infect Dis 15:e510-e513.
87. Steinhauer DA. 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258:1-20.
88. Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, Paulson JC, Wilson IA. 2006. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355:1143-1155.
89. Swindle MM, Makin A, Herron AJ, Clubb FJ Jr., Frazier KS. 2012. Swine as models in biomedical research and toxicology testing. Vet Pathol 49:344-356.
90. Takemae N, Parchariyanon S, Ruttanapumma R, Hiromoto Y, Hayashi T, Uchida Y, Saito T. 2011. Swine influenza virus infection in different age groups of pigs in farrow-to-finish farms in Thailand. Virol J 8:537.
91. Taubenberger JK, Morens DM. 2008. The pathology of influenza virus infections. Annu Rev Pathol 3:499-522.
92. Thangavel RR, Bouvier NM. 2014. Animal models for influenza virus pathogenesis, transmission, and immunology. J Immunol Methods.
93. Thomas JW, Touchman JW, Blakesley RW, Bouffard GG, Beckstrom-Sternberg SM, Margulies EH, Blanchette M, Siepel AC, Thomas PJ, McDowell JC, Maskeri B, Hansen NF, Schwartz MS, Weber RJ, Kent WJ, Karolchik D, Bruen TC, Bevan R, Cutler DJ, Schwartz S, Elnitski L, Idol JR, Prasad AB, Lee-Lin SQ, Maduro VV, Summers TJ, Portnoy ME, Dietrich NL, Akhter N, Ayele K, Benjamin B, Cariaga K, Brinkley CP, Brooks SY, Granite S, Guan X, Gupta J, Haghighi P, Ho SL, Huang MC, Karlins E, Laric PL, Legaspi R, Lim MJ, Maduro QL, Masiello CA, Mastrian SD, McCloskey JC, Pearson R, Stantripop S, Tiongson EE, Tran JT, Tsurgeon C, Vogt JL, Walker MA, Wetherby KD, Wiggins LS, Young AC, Zhang LH, Osoegawa K, Zhu B, Zhao B, Shu CL, De Jong PJ, Lawrence CE, Smit AF, Chakravarti A, Haussler D, Green P, Miller W, Green ED. 2003. Comparative analyses of multispecies sequences from targeted genomic regions. Nature 424:788-793.
94. Treanor JJ. 2010. Influenza Viruses, Including Avian Influenza and Swine Influenza. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practices of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone Elsevier. p 2265-2288.
95. Tripp RA, Tompkins SM. 2009. Animal models for evaluation of influenza vaccines. Curr Top Microbiol Immunol 333:397-412.
96. Turk JR, HendersonKK, VanvickleGD, Watkins J, LaughlinMH. 2005. Arterial endothelial function in a porcine model of early stage atherosclerotic vascular disease. Int J Exp Pathol 86:335-345.
97. van den Brand JM, Haagmans BL, van Riel D, Osterhaus AD, Kuiken T. 2014. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 151:83-112.
98. Van Poucke SG, Nicholls JM, Nauwynck HJ, Van Reeth K. 2010. Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution. Virol J 7:38.
99. Van Reeth K, Brown IH, Olsen CW. 2012. Influenza Virus. In:Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, eds. Diseases of Swine. 10th ed. Ames, IA:Wiley-Blackwell. p 557-571.
100. Van Reeth K, Nauwynck H, Pensaert M. 1998. Bronchoalveolar interferon- alpha, tumor necrosis factor-alpha, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans? J Infect Dis 177:1076-1079.
101. Van Reeth K, Van Gucht S, Pensaert M. 2002. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccinationimmune pigs. Viral Immunol 15:583-594.
102. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T. 2006. H5N1 virus attachment to lower respiratory tract. Science 312:399.
103. Vincent AL, Lager KM, Faaberg KS, Harland M, Zanella EL, Ciacci-Zanella JR, Kehrli ME Jr., Janke BH, Klimov A. 2010. Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza Other Respi Viruses 4:53-60.
104. Vincent AL, Ma W, Lager KM, Janke BH, Richt JA. 2008. Swine influenza viruses: a North American perspective. In:Maramorosch K, Shatkin AJ, Murphy FA, eds. Adv Virus Res. 2008/12/17 ed. Burlington, MA: Academic Press. p 127-154.
105. Vincent AL, Swenson SL, Lager KM, Gauger PC, Loiacono C, Zhang Y. 2009. Characterization of an influenza Avirus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. Vet Microbiol 137:51-59.
106. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. 1992. Evolution and ecology of influenza A viruses. Microbiol Rev 56:152-179.
107. Wiley DC, Skehel JJ. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annual Review of Biochemistry 56:365-394.
108. Wilkinson TM, Li CK, Chui CS, Huang AK, Perkins M, Liebner JC, Lambkin-Williams R, Gilbert A, Oxford J, Nicholas B, Staples KJ, Dong T, Douek DC, McMichael AJ, Xu XN. 2012. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med 18:274-280.
109. Yoon SW, Webby RJ, Webster RG. 2014. Evolution and ecology of influenza Aviruses. Curr Top Microbiol Immunol 385:359-375.
110. Zhou NN, Senne DA, Landgraf JS, Swenson SL, Erickson G, Rossow K, Liu L, Yoon K, Krauss S, Webster RG. 1999. Genetic reassortment of avian, swine, and human influenza Aviruses in American pigs. J Virol 73:8851-8856.
111. Zuckermann FA. 1999. Extrathymic CD4/CD8 double positive T cells. Vet Immunol Immunopathol 72:55-66.